![Fred Biehl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fred Biehl
Direktor/Vorstandsmitglied bei Aspargo Laboratories, Inc.
Aktive Positionen von Fred Biehl
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Aspargo Laboratories, Inc.
![]() Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Fred Biehl
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Aspargo Laboratories, Inc.
![]() Aspargo Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
- Börse
- Insiders
- Fred Biehl
- Erfahrung